The project’s publications:
Name | Journal | Author | DOI |
---|---|---|---|
Introduction to the EQIPD quality system | eLife, 2021 | Bespalov, Bernard, Gilis, et al. | DOI: 10.7554/eLife.63294 |
Sex differences in behaviour and molecular pathology in the 5XFAD model | BioRXIV, 2021 | Sil, Erfani, Lamb, Copland, Riedel, Plat | DOI: 10.3233/jad-210523 |
Choice of y-axis can mislead readers | Naunyn-Schmiedeberg’s Arch Pharmacol., 2020 | Betül R. Erdogan1 & Jan Vollert2 & Martin C. Michel | DOI: 10.1007/S00210-020-01926-X |
Reproducibility of animal research in light of biological variation. | Nat Rev Neurosci., 2020 | Voelkl B, Altman NS, Forsman A et al. | DOI: 10.1038/s41583-020-0313-3 |
Systematic review of guidelines for internal validity in the design, conduct and analysis of preclinical biomedical experiments involving laboratory animals. | BMJ Open Science, 2020 | Vollert J, Schenker E, Macleod M The EQIPD WP3 study group members, et al. | DOI: 10.1136/bmjos-2019-100046 |
Do overactive bladder symptoms and their treatment‐associated changes exhibit a normal distribution? Implications for analysis and reporting. | Neurourology and Urodynamics, 2020 | Amiri M, Murgas S, Stang A, Michel MC | DOI: 10.1002/nau.24275 |
Bespalov A, Michel MC, Steckler T (eds). Good Research Practice in Non-Clinical Pharmacology and Biomedicine | Handbook of Experimental Pharmacology, 2020 | Bespalov A, Michel MC, Steckler T | ISBN: 978-3-030-33658-5 |
Normalization of organ bath contraction data for tissue specimen size: does one approach fit all? | Naunyn-Schmiedeberg’s Arch Pharmacol, 2020 | Erdogan BR, Karaomerlioglu I, Yesilyurt ZE et al. | DOI: 10.1007/s00210-019-01727 |
New Author Guidelines for Displaying Data and Reporting Data Analysis and Statistical Methods in Experimental Biology | Molecular Pharmacology., 2020 | Michel MC, Murphy TJ and Motulsky HJ | DOI: 10.1124/mol.119.118927 |
Be positive about negatives-recommendations for the publication of negative (or null) results | Be positive about negatives-recommendations for the publication of negative (or null) results. Eur Neuropsychopharmacol 2019 | Bespalov A, Steckler T, Skolnick P | DOI: 10.1016/j.euroneuro.2019.10.007 |
Blinding and Randomization | Handbook of Experimental Pharmacology, Vol. 257 | Bespalov A, Wicke K, Castagné V | DOI: 10.1007/164_2019_279 |
Quality in Non-GxP Research Environment | Handbook of Experimental Pharmacology, Vol. 257 | Bongiovanni S, Purdue R, Kornienko O, and Bernard R | DOI: 10.1007/164_2019_274 |
Resolving the Tension Between Exploration and Confirmation in Preclinical Biomedical Research | Handbook of Experimental Pharmacology, Vol. 257 | Dirnagl U | DOI: 10.1007/164_2019_278 |
Building Robustness into Translational Research | Handbook of Experimental Pharmacology, Vol. 257 | Erdogan BR, Michel MC | DOI: 10.1007/164_2019_283 |